Lilly Alzheimer’s Drug Helped Patients in Small Trialwsj.com 1 pointalbertwang5 years ago2 commentsSaveHideCopy link On HNComments−albertwangOP5yDonanemab slowed cognitive and functional decline of patients with mild Alzheimer’s by 32% compared with placeboLink to press release: https://www.prnewswire.com/news-releases/lillys-donanemab-sl...−waynekerr5ynow that is good news....
Comments
Donanemab slowed cognitive and functional decline of patients with mild Alzheimer’s by 32% compared with placebo
Link to press release: https://www.prnewswire.com/news-releases/lillys-donanemab-sl...
now that is good news....